Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry
Research article
[키워드] abnormality
Accuracy
Acute kidney injury
acute respiratory distress syndrome
adjusted
Admission
AKIAcute Kidney Injury
Analysis
ARDSacute respiratory distress syndrome
area under the curve
assessment
AUCarea under the curve
BNPbrain natriuretic peptide
brain natriuretic peptide
C-reactive protein
cardiovascular disease
cardiovascular disease risk factor
chest X-ray
Coagulation
coefficient
cohort study
confidence interval
coronavirus disease-2019
COVID-19 patient
COVID-19coronavirus disease-2019
CRPC-reactive protein
CVDRFcardiovascular disease risk factor
D-dimer
D-dimer level
Deep vein thrombosis
develop
DVTdeep vein thrombosis
embolic
event
Factor
Hospitalization
hospitalized patient
identify
In-hospital
in-hospital mortality
Invasive mechanical ventilation
Japanese
lactate dehydrogenase
LASSOleast absolute shrinkage and selection operator
LDHlactate dehydrogenase
least absolute shrinkage and selection operator
limitation
Male sex
N-terminal prohormone of brain natriuretic peptide
NT-pro-BNPN-terminal prohormone of brain natriuretic peptide
Occurrence
operator
parameter
Patient
patients with COVID-19
potential risk
Predictive
Predictive model
PTEpulmonary thromboembolism
Pulmonary thromboembolism
receiver operating characteristic
reducing
Registered
registry
reported
Result
risk
risk factor
ROCreceiver operating characteristic
shown
significantly
Support
the primary endpoint
thromboembolic
Thromboembolic events
Thromboembolism
Venous Thromboembolism
VTEVenous Thromboembolism
was performed
WBCWhite blood cell
White blood cell
with COVID-19
[DOI] 10.1016/j.thromres.2022.06.007 [Article Type] Research article
[DOI] 10.1016/j.thromres.2022.06.007 [Article Type] Research article